________________________________________________________________________________________________________________________
puts us in a strong position for investment,” Stephen states.“ We’ ve expanded our global reach, and we now employ more than 600 people across the group, with manufacturing in the UK, Germany, and Argentina. With distribution and logistics spanning our core markets, including the US, we have a presence in more than 100 countries, and we estimate our solutions have reached more than one million patients.”
Stephen attributes the company’ s growth to four factors: investment, product quality, strategic clarity, and culture.“ Firstly, the investment and support offered by TA and Novo has not only allowed us to grow organically across the globe but has also fueled acquisitive growth to strengthen our position in the market,” Stephen expands.“ Next, although every manufacturer claims their products are the best, we genuinely believe our products are top-rated by
healthcare professionals, and we constantly strive to maintain that position.
“ In terms of our vision, when Mike joined in 2017, he outlined a very clear and defined strategy which is unwavering ever since. While other business strategies tend to change in line with quarterly results or new leadership, our clarity of purpose guides everyone across the company in the right direction. Lastly, our company culture is at the heart of all our success. We recognize that our employees are crucial to our success, and we’ re passionate about supporting them to do their best work, making us truly One Bicomposites.”
Elaborating on company culture and employee engagement, Stephen continues:“ We’ re partnering with a business excellence consultancy called The Lean Orange, which is a licensed Shingo Institute™ affiliate, to create a shared purpose, vision and ideal
Founded in 2015, we manufacture precision plastic components for the medical industry using state-of-the-art technology.
From concept to production, we deliver safe, rigorously tested products, supported by 3D printing, pad printing, project management, validation, and bioburden testing.
Based in Staffordshire and operating globally, we are a trusted manufacturing partner to Biocomposites, providing design support through to final product approval.
MMP are a class 5 and class 7 cleanroom injection moulding company approved to ISO13485
DISCOVER MORE medical-mouldedproducts. co. uk
UK Cleanroom Injection Moulding
68